Risk of cardiovascular events in patients diagnosed with venous thromboembolism

Cardiovascular disease is a leading cause of mortality globally. Whether venous thromboembolism (VTE) increases the risk of subsequent arterial cardiovascular events (ACVE) remains unclear. We examined the risk of future ACVE in a large emergency department (ED) cohort of patients with and without V...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:The American journal of medicine
Hlavní autori: Lonnberg, Frida, Siddiqui, Anwar J
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 29.08.2025
Predmet:
ISSN:1555-7162, 1555-7162
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Cardiovascular disease is a leading cause of mortality globally. Whether venous thromboembolism (VTE) increases the risk of subsequent arterial cardiovascular events (ACVE) remains unclear. We examined the risk of future ACVE in a large emergency department (ED) cohort of patients with and without VTE. This retrospective cohort study included all adults (≥18 years) presenting to five EDs in Stockholm 2016-2017. Patients diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE) were identified; the remaining patients formed the comparison group. Individuals with prior ACVE were excluded. Fine-Gray subdistribution hazard models estimated crude and adjusted hazard ratios (HRs) for ACVE, cardiovascular death, and all-cause mortality, adjusting for age, sex, and key comorbidities. Mean follow-up was 1.2 years for ACVE and 2.1 years for mortality. Among 308,779 patients, 3,610 had DVT and 2,358 had PE. ACVE occurred in 70 (1.9%) of DVT and 59 (2.5%) of PE patients, versus 4,870 (1.6%) of patients in the comparison group. Adjusted HRs for ACVE in DVT were 0.77 (95% CI, 0.47-1.25) at 30 days, 0.76 (0.58-0.99) at 1 year, and 0.74 (0.59-0.94) at full follow-up. For PE, the corresponding HRs were 0.46 (0.22-0.96), 0.87 (0.65-1.16), and 0.86 (0.67-1.12), respectively. All-cause mortality was significantly elevated in both groups: HRs for DVT and PE were 1.64 (1.48-1.82) and 2.37 (2.14-2.63), respectively. VTE was not associated with an increased risk of ACVE. Both DVT and PE were linked to significantly elevated all-cause mortality.
AbstractList Cardiovascular disease is a leading cause of mortality globally. Whether venous thromboembolism (VTE) increases the risk of subsequent arterial cardiovascular events (ACVE) remains unclear. We examined the risk of future ACVE in a large emergency department (ED) cohort of patients with and without VTE. This retrospective cohort study included all adults (≥18 years) presenting to five EDs in Stockholm 2016-2017. Patients diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE) were identified; the remaining patients formed the comparison group. Individuals with prior ACVE were excluded. Fine-Gray subdistribution hazard models estimated crude and adjusted hazard ratios (HRs) for ACVE, cardiovascular death, and all-cause mortality, adjusting for age, sex, and key comorbidities. Mean follow-up was 1.2 years for ACVE and 2.1 years for mortality. Among 308,779 patients, 3,610 had DVT and 2,358 had PE. ACVE occurred in 70 (1.9%) of DVT and 59 (2.5%) of PE patients, versus 4,870 (1.6%) of patients in the comparison group. Adjusted HRs for ACVE in DVT were 0.77 (95% CI, 0.47-1.25) at 30 days, 0.76 (0.58-0.99) at 1 year, and 0.74 (0.59-0.94) at full follow-up. For PE, the corresponding HRs were 0.46 (0.22-0.96), 0.87 (0.65-1.16), and 0.86 (0.67-1.12), respectively. All-cause mortality was significantly elevated in both groups: HRs for DVT and PE were 1.64 (1.48-1.82) and 2.37 (2.14-2.63), respectively. VTE was not associated with an increased risk of ACVE. Both DVT and PE were linked to significantly elevated all-cause mortality.
Cardiovascular disease is a leading cause of mortality globally. Whether venous thromboembolism (VTE) increases the risk of subsequent arterial cardiovascular events (ACVE) remains unclear. We examined the risk of future ACVE in a large emergency department (ED) cohort of patients with and without VTE.BACKGROUNDCardiovascular disease is a leading cause of mortality globally. Whether venous thromboembolism (VTE) increases the risk of subsequent arterial cardiovascular events (ACVE) remains unclear. We examined the risk of future ACVE in a large emergency department (ED) cohort of patients with and without VTE.This retrospective cohort study included all adults (≥18 years) presenting to five EDs in Stockholm 2016-2017. Patients diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE) were identified; the remaining patients formed the comparison group. Individuals with prior ACVE were excluded. Fine-Gray subdistribution hazard models estimated crude and adjusted hazard ratios (HRs) for ACVE, cardiovascular death, and all-cause mortality, adjusting for age, sex, and key comorbidities. Mean follow-up was 1.2 years for ACVE and 2.1 years for mortality.METHODSThis retrospective cohort study included all adults (≥18 years) presenting to five EDs in Stockholm 2016-2017. Patients diagnosed with deep vein thrombosis (DVT) or pulmonary embolism (PE) were identified; the remaining patients formed the comparison group. Individuals with prior ACVE were excluded. Fine-Gray subdistribution hazard models estimated crude and adjusted hazard ratios (HRs) for ACVE, cardiovascular death, and all-cause mortality, adjusting for age, sex, and key comorbidities. Mean follow-up was 1.2 years for ACVE and 2.1 years for mortality.Among 308,779 patients, 3,610 had DVT and 2,358 had PE. ACVE occurred in 70 (1.9%) of DVT and 59 (2.5%) of PE patients, versus 4,870 (1.6%) of patients in the comparison group. Adjusted HRs for ACVE in DVT were 0.77 (95% CI, 0.47-1.25) at 30 days, 0.76 (0.58-0.99) at 1 year, and 0.74 (0.59-0.94) at full follow-up. For PE, the corresponding HRs were 0.46 (0.22-0.96), 0.87 (0.65-1.16), and 0.86 (0.67-1.12), respectively. All-cause mortality was significantly elevated in both groups: HRs for DVT and PE were 1.64 (1.48-1.82) and 2.37 (2.14-2.63), respectively.RESULTSAmong 308,779 patients, 3,610 had DVT and 2,358 had PE. ACVE occurred in 70 (1.9%) of DVT and 59 (2.5%) of PE patients, versus 4,870 (1.6%) of patients in the comparison group. Adjusted HRs for ACVE in DVT were 0.77 (95% CI, 0.47-1.25) at 30 days, 0.76 (0.58-0.99) at 1 year, and 0.74 (0.59-0.94) at full follow-up. For PE, the corresponding HRs were 0.46 (0.22-0.96), 0.87 (0.65-1.16), and 0.86 (0.67-1.12), respectively. All-cause mortality was significantly elevated in both groups: HRs for DVT and PE were 1.64 (1.48-1.82) and 2.37 (2.14-2.63), respectively.VTE was not associated with an increased risk of ACVE. Both DVT and PE were linked to significantly elevated all-cause mortality.CONCLUSIONSVTE was not associated with an increased risk of ACVE. Both DVT and PE were linked to significantly elevated all-cause mortality.
Author Siddiqui, Anwar J
Lonnberg, Frida
Author_xml – sequence: 1
  givenname: Frida
  surname: Lonnberg
  fullname: Lonnberg, Frida
  organization: Department of Medicine, Karolinska Institute, Solna, Sweden; Acute and Reparative Medicine Theme, Karolinska University Hospital, Stockholm, Sweden
– sequence: 2
  givenname: Anwar J
  surname: Siddiqui
  fullname: Siddiqui, Anwar J
  email: anwar.siddiqui@ki.se
  organization: Department of Medicine, Karolinska Institute, Solna, Sweden; Acute and Reparative Medicine Theme, Karolinska University Hospital, Stockholm, Sweden. Electronic address: anwar.siddiqui@ki.se
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40886975$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtLxEAQhAdZcR_6D0Tm6CVx3kmOsviChQXRc-hkOu7EJLNmkhX_vUFXsKHoOnwURS3JrPMdEnLJWcwZNzd1DG3doo0FEzpmacykPiELrrWOEm7E7J-fk2UINZsu0-aMzBVLU5MlekG2zy68U1_REnrr_AFCOTbQUzxgNwTqOrqHwf146-Ct8wEt_XTDjk6AHwMddr1vC4-TGhfac3JaQRPw4vhX5PX-7mX9GG22D0_r201USmN0xKESkklRGJvKqpBJKmWascIWqLgWqgTkIqkkMlBGc1RpkoG2FS8tCpWBWJHr39x97z9GDEPeulBi00CHU61cCmVkollmJvTqiI7FtFe-710L_Vf-N4L4BhhAYt0
ContentType Journal Article
Copyright Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Copyright © 2025. Published by Elsevier Inc.
Copyright_xml – notice: Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
– notice: Copyright © 2025. Published by Elsevier Inc.
DBID NPM
7X8
DOI 10.1016/j.amjmed.2025.08.035
DatabaseName PubMed
MEDLINE - Academic
DatabaseTitle PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1555-7162
ExternalDocumentID 40886975
Genre Journal Article
GroupedDBID ---
--K
-~X
.1-
.FO
0R~
123
1B1
1P~
1RT
1~5
23M
4.4
457
4CK
4G.
5RE
6J9
7-5
AAEDT
AAEDW
AAFWJ
AALRI
AAWTL
AAXUO
ABLJU
ABMAC
ABOCM
ABPPZ
ACGFO
ACIUM
ACKOT
ACPRK
ACVFH
ADBBV
ADCNI
AENEX
AEVXI
AFFNX
AFJKZ
AFRHN
AFTJW
AGCQF
AGHFR
AHMBA
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BELOY
BKOMP
C5W
CS3
EBS
EFJIC
EFKBS
EX3
F5P
FDB
G-Q
GBLVA
HEA
IH2
IHE
J1W
J5H
K-O
KOM
L7B
LZ2
M29
M41
MO0
N9A
NPM
O9-
OD.
OO~
P2P
PC.
PQQKQ
ROL
RPZ
SAE
SEL
SES
SSZ
TWZ
UHB
UNMZH
UV1
WH7
WOW
XH2
YOC
YYQ
Z5R
ZUP
7X8
ID FETCH-LOGICAL-c3665-1af23032b6d83fb37833890bdbe41524cae127f3e0a4651e4879a5df1cde249a2
IEDL.DBID 7X8
ISSN 1555-7162
IngestDate Thu Oct 02 21:36:59 EDT 2025
Sat Sep 20 02:13:01 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Pulmonary embolism
Deep vein thrombosis
Emergency department
Arterial cardiovascular events
Venous thromboembolism
Language English
License Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3665-1af23032b6d83fb37833890bdbe41524cae127f3e0a4651e4879a5df1cde249a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doi.org/10.1016/j.amjmed.2025.08.035
PMID 40886975
PQID 3246375096
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3246375096
pubmed_primary_40886975
PublicationCentury 2000
PublicationDate 2025-Aug-29
PublicationDateYYYYMMDD 2025-08-29
PublicationDate_xml – month: 08
  year: 2025
  text: 2025-Aug-29
  day: 29
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The American journal of medicine
PublicationTitleAlternate Am J Med
PublicationYear 2025
SSID ssj0000956
Score 2.484891
SecondaryResourceType online_first
Snippet Cardiovascular disease is a leading cause of mortality globally. Whether venous thromboembolism (VTE) increases the risk of subsequent arterial cardiovascular...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
Title Risk of cardiovascular events in patients diagnosed with venous thromboembolism
URI https://www.ncbi.nlm.nih.gov/pubmed/40886975
https://www.proquest.com/docview/3246375096
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC62GSzu9mTSG3x0lqkSm9hX8GoTWoj_n5nk5QieBA8JKckLLOzM_PNTL5B6EqCW7YmksQGOgKAojnRLrKEBZpFxtk4drYaNiGGw3gykaMm4VY2bZULm1gZalsYnyO_BsfPqXdv_Gb2QfzUKF9dbUZorKIWhVDGH0wxWbKFe5K9ii-VMeKZkha_zlX9XWr6Cv4GEGLIKhLPZuDbr0Fm5Wz62_9d5g7aasJMfFvrxS5acfke2hg0hfR99PCYlW-4SHH3Rz8q7vn2xxJnOR7VhKslvqub8ZzFPmeLnytSVzx-mRdTXTi43rNyeoCe-r1x9540sxWIoZwzEqgUwAcNNbcxTTUVMWBV2dEWdgpcemSUC0KRUtdRflq6A1wjFbNpYKwDxKbCQ7SWF7k7RlgqI42K4YMA7TqCK6E100EsKNgPeLKNLheiSkB3fUFC5Q6WmiyF1UZHtbyTWU2ykURg_rgU7OQPb5-iTb-NPtUbyjPUSuHkunO0br4-s3J-USkF3IejwTfVFsFi
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+of+cardiovascular+events+in+patients+diagnosed+with+venous+thromboembolism&rft.jtitle=The+American+journal+of+medicine&rft.au=Lonnberg%2C+Frida&rft.au=Siddiqui%2C+Anwar+J&rft.date=2025-08-29&rft.eissn=1555-7162&rft_id=info:doi/10.1016%2Fj.amjmed.2025.08.035&rft_id=info%3Apmid%2F40886975&rft_id=info%3Apmid%2F40886975&rft.externalDocID=40886975
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1555-7162&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1555-7162&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1555-7162&client=summon